Skip to main content
PeptoClinic

CJC-1295 (sin DAC)

Modified GRF(1-29) tetrasubstituted analogue without drug affinity complex.

Also known as: CJC-1295 no DAC, CJC1295 without DAC, Modified GRF 1-29, Mod GRF (1-29)

Growth hormone axis≥99% HPLCSizes available: 5 mg – 20 mgPhysician-reviewed

What is CJC-1295 (sin DAC)?

CJC-1295 without DAC, also referred to as Modified GRF(1-29), is a tetrasubstituted GHRH analogue engineered for increased enzymatic stability relative to native GHRH. It serves as a research standard in studies of somatotroph receptor binding and secretagogue pharmacokinetics.

Documented research areas

  • GHRH analogue
  • Receptor binding
  • Peptide stability

CJC-1295 (sin DAC) specifications

CJC-1295 (sin DAC) — supply specification. Supplied after a physician reviews your consultation.
PropertySpecification
ClassificationModified GRF (1-29), no DAC
Also known asCJC-1295 no DAC, CJC1295 without DAC, Modified GRF 1-29, Mod GRF (1-29)
Purity≥99% HPLC
CAS number863288-34-0
Molecular formulaC152H252N44O42
Molecular weight3367.9 g/mol
Vial sizes available5 mg, 10 mg, 20 mg
Intended useSupplied after physician review — not an approved medicine
Physical formLyophilised powder
Storage-20 °C, protected from light
ReconstitutionBacteriostatic water (quoted separately)
TestingHPLC + mass spectrometry, per batch
DispatchInsulated cold-chain, tracked, from Argentina or the United States

Certificate of analysis

The CoA for the specific batch you would receive is reviewed during your consultation and ships with the material.

Request this batch CoA

Frequently asked questions

How do I know a lot is what it claims to be?

From that lot's certificate of analysis, not from what the supplier asserts. The certificate names the laboratory that took the measurement, the date, the task number, the method and the purity found. PeptoClinic publishes the full reports uncropped, exactly as the laboratory printed them.

Can it be used in humans?

Only after a physician has reviewed your intake, and only as the guidance issued with your order sets out. None of these compounds is approved by the FDA or ANMAT for that use — which is precisely why the review exists, and why no protocol is published here for anyone to apply on their own.

What is a certificate of analysis and how do you read one?

It is the report an analytical laboratory issues on a specific sample. Four things are worth checking: which compound it claims to have measured, by what method (HPLC for purity, mass spectrometry for identity), what figure it found, and whether the task number can be verified against the laboratory. A certificate with no verifiable task number is a picture.

Why does PeptoClinic publish no prices?

Because there is no single price. Cost turns on quantity, vial size, the documentation the programme needs and the dispatch route. Each compound is quoted in writing after a free, no-obligation technical consultation, normally within one business day.

Physician-reviewed supply

Compounds on this site are supplied after an intake that a physician reviews one by one. None of them has been evaluated or approved by the FDA, ANMAT or any equivalent authority for the use it is requested for, and nothing on this page is a recommendation to start one on your own judgement. Whether a compound suits a given person is the reviewing physician's decision.

Compliance →
CJC-1295 (sin DAC) 5 mg vial — lyophilised peptide, ≥99% HPLC

CJC-1295 (sin DAC)

Modified GRF(1-29) tetrasubstituted analogue without drug affinity complex.

Format
Purity
≥99% HPLC
Physical form
Lyophilised powder
Testing
HPLC + mass spectrometry, per batch

No prices are published on this site. Every compound is quoted through a consultation.

Consult about CJC-1295 (sin DAC)

No payment. No account. No obligation. One business day response.

Request the Certificate of Analysis (CoA)

Researchers also ask about

← Back to all compounds
Request a consultation